HER Act
- house
- senate
- president
Last progress June 5, 2025 (6 months ago)
Introduced on June 5, 2025 by Shontel M. Brown
House Votes
Referred to the House Committee on Energy and Commerce.
Senate Votes
Presidential Signature
AI Summary
This bill funds research on how chemicals in everyday personal care products—like shampoos, lotions, and cosmetics—that can interfere with hormones may affect women’s reproductive health. The health department will give research grants and must publish a public report every five years with what they learn, including a list of safer and harmful products and ideas to expand the FDA’s power to regulate these ingredients.
It also gives grants to states to study these products’ effects and run public awareness campaigns about safer alternatives. States must share what they find in reports every five years. The bill defines an endocrine‑disrupting chemical as one that mimics, blocks, or interferes with the body’s hormones.
- Who is affected: People who use personal care products, especially women; state health agencies; researchers; and the FDA, which could get more tools to oversee ingredients.
- What changes: New federal research grants; state grants for investigations and education; public reports listing safer and harmful products and suggesting policy steps to strengthen FDA oversight.
- When: Federal and state reports are due within five years and then every five years after that.